Cash Flow Nephrocare Heal. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Profit Before Tax
87.00
33.00
-8.00
-27.00
Adjustment
93.00
80.00
68.00
64.00
Changes In working Capital
-44.00
-33.00
-53.00
-18.00
Cash Flow after changes in Working Capital
136.00
80.00
6.00
19.00
Cash Flow from Operating Activities
135.00
72.00
11.00
14.00
Cash Flow from Investing Activities
-125.00
-51.00
-75.00
-129.00
Cash Flow from Financing Activities
54.00
26.00
59.00
121.00
Net Cash Inflow / Outflow
64.00
47.00
-4.00
6.00
Opening Cash & Cash Equivalents
61.00
14.00
18.00
12.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
125.00
61.00
14.00
18.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nephrocare Heal.
Figures in Cr
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 87.26% vs 541.35% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
135.35
72.28
87.26%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
